Our observation of elevated anti-gut microbial IgA antibodies supports the evidence for gut barrier dysfunction in severe COVID-19 that may necessitate containment of gut microbiota translocated to the circulation and possibly the CSF53–55. This evidence concerns the gene CD79A and COVID-19.